🟡AOD-9604 | 5mg

AOD-9604 exerts its effects primarily by mimicking the lipolytic activity of hGH without influencing insulin levels or inducing hyperglycemia. It activates the beta-3 adrenergic receptor and stimulates lipolysis, the breakdown of stored fat in adipose tissue. This receptor is significant in regulating energy expenditure and fat oxidation. Preclinical studies have demonstrated AOD-9604’s ability to reduce body fat in animal models, which has led to interest in its potential use for obesity management.

Unlike full-length hGH, AOD-9604 does not induce hyperglycemia or promote the growth of lean muscle mass, making it a safer option for targeting fat loss. Clinical trials have evaluated its safety and efficacy, showing that AOD-9604 is well-tolerated with a favorable safety profile. Its specific targeting of adipose tissue for fat reduction positions AOD-9604 as a promising candidate for therapeutic interventions aimed at managing obesity and metabolic disorders.